Prognostic significance of RCAS1 expression in relation to the infiltration of dendritic cells and lymphocytes in patients with esophageal carcinoma

Digestive Diseases and Sciences

Volumn 52, Issue 2, 2007, Pages 549-554

  Tsujitani, Shunichi ^a   Saito, Hiroaki ^a   Oka, Shinichi ^a   Sakamoto, Teruhisa ^a   Kanaji, Shingo ^a   Tatebe, Shigeru ^a   Ikeguchi, Masahide ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Dendritic cell; Esophageal carcinoma; RCAS1; Tumor infiltrating lymphocyte

Indexed keywords

RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELL; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CELL DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR ASSOCIATED LEUKOCYTE;

AGED; ANTIGENS, NEOPLASM; CARCINOMA; DENDRITIC CELLS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 33846847993     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9408-6     Document Type: Article

References (31)

1. Pawelec G (2004) Tumour escape:antitumour effectors too much of a good thing? Cancer Immunol Immunother 53:262-274
2. Suda T, Nagata S (1994) Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179:873-879
3. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR(1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion? Nat Med 2:1361-1366
4. Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F (1998) The Fas counterattack in vivo:apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol 160:5669-5675
5. Ikeguchi M, Saito H, Katano K, Tsujitani S, Maeta M, Kaibara N (1997) Correlation between the lymphocytic infiltration of tumors and the proliferative activity of cancer cells from surgically treated esophageal carcinoma. Oncology 54:311-317
6. Nagata S (1996) Fas ligand and immune evasion. Nat Med 2:1306-1307
7. Chappell DB, Restifo NP (1998) T cell-tumor cell: A fatal interaction? Cancer Immunol Immunother 47:65-71
8. Nakashima M, Sonoda K, Watanabe T (1999) Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 5:938-942
9. Iwasaki T, Nakashima M, Watanabe T, Yamamoto S, Inoue Y, Yamanaka H, Matsumura A, Iuchi K, Mori T, Okada M (2000) Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Int J Cancer 89:488-493
10. Noguchi K, Enjoji M, Nakamuta M, Nakashima M, Nishi H, Choi I, Taguchi K, Kotoh K, Shimada M, Sugimachi K, Tsuneyoshi M, Nawata H, Watanabe T (2001) Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma. Cancer Lett 168:197-202
11. Takahashi H, Iizuka H, Nakashima M, Wada T, Asano K, Ishida-Yamamoto A, Watanabe T (2001) RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. J Dermatol Sci 26:140-144
12. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T (1996) A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 77:1501-1509
13. Sonoda K, Kaku T, Kamura T, Nakashima M, Watanabe T, Nakano H (1998) Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias. Clin Cancer Res 4:1517-1520
14. Kaku T, Sonoda K, Kamura T, Hirakawa T, Sakai K, Amada S, Ogawa S, Kobayashi H, Nakashima M, Watanabe T, Nakano H (1999) The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clin Cancer Res 5:1449-1453
15. Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H (2000) The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Gynecol Oncol 79:424-429
16. Matsushima T, Nakashima M, Oshima K, Abe Y, Nishimura J, Nawata H, Watanabe T, Muta K (2001) Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 98:313-321
17. Banchereau J, Steinman R (1998) Dendritic cells and the control of immunity. Nature 392:245-252
18. International Union Against Cancer (1997) TNM classification of malignant tumors. 5th ed. John Wiley, New York
19. Fukuda K, Tsujitani S, Maeta Y, Yamaguchi K, Ikeguchi M, Kaibara N (2002) The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma. Gastric Cancer 5:220-227
20. Saito H, Tsujitani S, Ikeguchi M, Maeta M, Kaibara N (1998) Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br J Cancer 78:1573-1577
21. Stein HJ, Siewert JR (2004) Improved prognosis of resected esophageal cancer. World J Surg 28:520-525
22. Disis M, Calenoff E, McLaughlin G, Murphy A, Chen W, Groner B, Jeschke M, Lydon N, McGlynn E, Livingston R (1994) Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res 54:16-20
23. DisisM , Knutson K, Schiffman K, Rinn K, McNeel D (2000) Preexistent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer. Breast Cancer Res Treat 62:245-252
24. Runger TM, Klein CE, Becker JC, Brocker EB (1994) The role of genetic instability, adhesion, cell motility, and immune escape mechanisms in melanoma progression. Curr Opin Oncol 6:188-196
25. Ferrone S, Marincola FM (1995) Loss of HLA class I antigens by melanoma cells:molecular mechanisms, functional significance and clinical relevance. Immunol Today 16:487-494
26. O'Sullivan GC, Corbett AR, Shanahan F, Collins JK (1996) Regional immunosuppression in esophageal squamous cancer: evidence from functional studies with matched lymph nodes. J Immunol 157:4717-4720
27. O'Mahony AM, O'Sullivan GC, O'Connell J, Cotter TG, Collins JK (1993) An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J Immunol 151:4847-4856
28. Ikeguchi M, Ohoro S, Maeda Y, Yamaguchi K, Fukuda K, Shirai H, Kondo A, Tsujitani S, Kaibara N (2003) Protein and gene expression of tumor-associated antigen RCAS1 in esophageal squamous cell carcinoma. Oncol Rep 10:1891-1894
29. Kubokawa M, Nakashima M, Yao T, Ito KI, Harada N, Nawata H, Watanabe T (2001) Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. Int J Oncol 19:695-700
30. Kato H, Nakajima M, Masuda N, Faried A, Sohda M, Fukai Y, Miyazaki T, Fukuchi M, Tsukada K, Kuwano H (2005) Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis. J Surg Oncol 90:89-94
31. Nakakubo Y, Hida Y, Miyamoto M, Hashida H, Oshikiri T, Kato K, Suzuoki M, Hiraoka K, Ito T, Morikawa T, Okushiba S, Kondo S, Katoh H (2002) The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus. Cancer Lett 177:101-105